Is there a pharmacological basis for differences in 5-HT3-receptor antagonist efficacy in refractory patients?

Ronald de Wit, M Aapro, PR Blower

Research output: Contribution to journalArticleAcademicpeer-review

31 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)231-238
Number of pages8
JournalCancer Chemotherapy & Pharmacology
Volume56
Issue number3
DOIs
Publication statusPublished - 2005

Cite this